Cellectar Biosciences, Inc. · NASDAQ:CLRB

Stonepine Capital Management, LLC reported a 9.90% stake in Cellectar Biosciences, Inc. (Schedule 13G)

Event May 4, 2026 · Filed May 11, 2026

Stonepine Capital Management, LLC reported a 9.90% stake in Cellectar Biosciences, Inc., 863,277 shares, as a passive investor on May 4, 2026. Filed May 11, 2026 (Schedule 13G).

Stake
9.90%
Shares
863,277
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Stonepine Capital Management, LLC9.90%863,277
Stonepine Capital, L.P.9.90%863,277
Stonepine GP, LLC9.90%863,277
Jon M. Plexico9.90%863,277

Source

View original at SEC

Related